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Introduction
Intracranial arteriovenous fistulas (AVFs) are relatively
rare, occurring at different sites of the intracranium,
with variable shunt volume. The fistula is classified as
low or high flow depending on the size of the shunt
and the steal phenomenon.1–4 In most cases, it is a
single fistula with a large shunt having a short and
direct route, and the blood flow is high and rapid with
a moderate to severe steal phenomenon because of the
large pressure gradient between the arterial and venous
systems. A fistula may occur spontaneously or as the
result of trauma. Sequelae of intracranial AVFs include
an arterial steal phenomenon with cerebral
hypoperfusion, and increased flow in cerebral veins
resulting in intracranial venous congestion or
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Background: This study reports our experience in performing transarterial Guglielmi detachable coil (GDC) embolization
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or associated with arteriovenous malformation (n = 3); 1 was a tentorium AVF.
Results: All of these high-flow AVFs were successfully occluded by a single session of transarterial GDC embolization.
In 8 patients with TCCFs, the nearby parent arteries were preserved. The average number of coils was 8 and the
average length was 126 cm. All AVF-related symptoms resolved immediately or gradually on clinical follow-up.
No significant procedure-related neurologic complication or recurrent AVF was seen. All 13 patients were followed
up clinically for an average of 16 months (range, 6–25 months).
Conclusion: Transarterial GDC embolization is a useful method in the treatment of intracranial high-flow AVFs. GDC
affords more control in the placement of coils and proved both efficient and safe in the management of intracranial
high-flow AVFs. [J Chin Med Assoc 2006;69(2):80–85]
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hemorrhage, headache, bruit, tinnitus, or vertigo.
AVF involving the cavernous sinus may cause bruit,
proptosis, chemosis, and symptoms referable to cranial
nerves. Treatment of AVF is selective occlusion of the
fistula proper. Endovascular treatment has become
the therapy of choice for most cases. Various
endovascular approaches and embolic materials can be
used. High-flow fistulas have commonly been treated
with a detachable balloon via the transarterial route.1,2,5
Since the introduction of the Guglielmi detachable
coil (GDC) (Boston Scientific Corporation, Fremont,
CA, USA), there has been great interest in its use as a
tool for the treatment of intracranial aneurysm.6,7
Little has been written about the application of this
device to other cerebrovascular pathologies and only
case reports or small series have been reported.4,8–10
©2006 Elsevier. All rights reserved.
*Correspondence to: Dr. Chao-Bao Luo, Department of Radiology, Taipei Veterans General Hospital, 201,
Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
E-mail: cbluo@vghtpe.gov.tw • Received: June 20, 2005 • Accepted: December 22, 2005
J Chin Med Assoc • February 2006 • Vol 69 • No 2 81
Embolization of intracranial arteriovenous fistulas
The purpose of this study is to present our
experiences in performing transarterial GDC
embolization for intracranial high-flow AVFs and to
evaluate its efficacy and safety.
Methods
From August 2001 to August 2004, 42 patients with
intracranial high-flow AVFs were referred to our
institute for endovascular management. Of these, 13
patients with 14 AVFs were treated by transarterial
GDC embolization. The clinical data of the 13 patients
with 14 AVFs are summarized in Table 1. There were
6 men and 7 women aged from 4 to 56 years (mean,
27 years). Their clinical manifestations were chemosis
(n = 7), proptosis (n = 4), bruit (n = 4), headache
(n = 3), intracranial hemorrhage (n = 2) after surgical
treatment, and seizure (n = 1). Among the 14 AVFs,
8 were traumatic carotid-cavernous fistulas (TCCFs,
Figure 1); 2 were AVFs at the temporal (Figure 2) or
parieto-occipital lobe; 1 was a tentorium AVF (Figure
3); and 3 were associated with cerebral arteriovenous
malformation (AVM) at the parieto-occipital, frontal
or temporal lobes, respectively. One patient had
received radiosurgery 3 years before embolization
with partial remission of the AVM, and the other 2
underwent embolization of the AVFs followed by
radiosurgery for the treatment of the AVMs. In the 8
TCCFs, transarterial detachable balloon embolization
was selected as first-line embolization. However,
residual high-flow fistulas remained in 3 after balloon
detachment at the cavernous sinus because of failure to
negotiate the detachable balloon into the cavernous
sinus due to a tortuous or stenotic carotid artery
(n = 3) and/or small fistula tract (n = 2).
Endovascular procedures for all AVFs were
performed under local (n = 1) or general (n = 12)
anesthesia via a femoral approach. Activated clotting
time was maintained at a value twice the baseline value.
A 6F or 5F guiding catheter was positioned in the
parent artery, followed by a microcatheter, which was
navigated to the AVF. Occlusion of the AVF was
initiated by selection of the proper GDC. Because the
AVF was mechanically occluded by the coil mass, we
preferred to use the large-caliber GDC (e.g. GDC-18)
rather than the drug-coated GDC (e.g. Matrix) to
shorten the procedure time and reduce the cost. In our
series, the GDCs were densely packed into the
cavernous sinus in 8 patients with TCCFs; in 5 AVFs,
GDCs were placed into the fistula proper, including
the distal artery and proximal venous sac or pouch,
until the fistula flow was disconnected.
A postembolization angiogram was done
immediately after completion of the procedure to
check for occlusion of the fistula. Of the 14 AVFs, 8
had follow-up angiography from 1 week to 6 months
after embolization.
Results
Results and follow-up findings are shown in Table 1.
Complete fistula closures were documented on




Location and Associated Coil number/ Outcome of Follow-up
(yr) type of AVF vascular lesions length (cm) AVFs (mo)
1 M/35 Chemosis TCCF Nil 2/16 Cure 10
2 F/24 Chemosis, proptosis TCCF Nil 13/234 Cure 8
3 M/21 Chemosis, bruit TCCF Nil 7/92 Cure 25
4 F/56 Chemosis, bruit, proptosis Residual TCCF Nil 6/78 Cure 13
5 F/39 Chemosis, bruit, proptosis Bilateral TCCFs Nil 9/88 Pseudoaneurysm 18
6/30 formation
6 F/52 Chemosis, bruit Residual TCCF Nil 6/73 Cure 15
7 M/23 Chemosis, proptosis Residual TCCF Contralateral TCCF 5/20 Cure 23
8 M/35 Headache Temporal AVF Temporal AVM 4/110 Cure 19
9 M/8 ICH Temporal AVF Nil 12/268 Cure 12
10 F/7 Headache Occipital AVF Nil 12/280 Cure 9
11 M/4 Seizure Parieto-occipital AVF Parieto-occipital AVM 8/138 Cure 24
12 F/27 Headache Frontal AVF Frontal AVM 9/111 Cure 6
13 F/16 ICH Tentorium AVF Nil 6/94 Cure 20
GDC = Guglielmi detachable coil; AVF = arteriovenous fistula; TCCF = traumatic carotid-cavernous fistula; AVM = arteriovenous malformation;
ICH = intracranial hemorrhage.
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postembolization angiograms in 10 AVFs (Figures 1–
3), whereas a small residual flow remained in the other
3 (Figure 4). In all 3 residual AVFs, spontaneous
thrombosis was expected, the procedure was
discontinued, and total occlusion of the AVFs was
confirmed by follow-up angiograms 3–4 days later.
One patient experienced temporary impairment of
cranial nerve function, which resolved completely
within 6 months. One patient with TCCF had an
asymptomatic pseudoaneurysm formation at the
Figure 1. A 24-year-old woman presented with chemosis and proptosis because of traumatic carotid-cavernous fistula (TCCF). (A) Right
frontal carotid angiogram shows a TCCF; a detachable balloon was selected to occlude the fistula, but failed to negotiate into the fistula
due to a tortuous and stenotic internal carotid artery (ICA). (B) Thirteen Guglielmi detachable coils with a total coil length of 238 cm were
employed to occlude the fistula and cavernous sinus and resulted in total occlusion of the fistula with preservation of the ICA.
Figure 2. An 8-year-old boy had right temporal arteriovenous fistula (AVF) and presented with intracerebral hemorrhage after surgical
treatment. (A) Right lateral carotid angiogram revealed a high-flow AVF at the right temporal lobe with a big venous pouch.
(B) Transarterial Guglielmi detachable coil (GDC) embolization with total occlusion of the fistulas was achieved by the placement of
12 GDCs with a total coil length of 268 cm into the fistula tract and venous pouch.
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cavernous portion of the internal carotid artery (ICA)
because of insufficient packing of the cavernous fistula.
No significant procedure-related neurologic
complications or recurrent AVFs were observed. In 8
patients with follow-up angiograms, no evidence
of recurrent AVF was found. All 13 patients had
been followed up clinically for an average of 16
months (range, 6–25 months). In all patients, the
clinical symptoms and signs related to fistula, such as
bruit, chemosis, proptosis, headache, and seizure,
immediately or gradually resolved after endovascular
treatment.
Discussion
The best endovascular approach for a high-flow AVF
is via the transfemoral artery because of relatively easy
access. The transvenous route is generally considered
in low-flow AVFs involving a large dural sinus11,12 or
when the arterial route is blocked or access fails. An
important concept in endovascular management of
high-flow AVFs is to deliver the embolic materials
precisely to the fistula site, including the adjacent
distal artery and proximal venous drain or pouch.
Unintentional distal embolization with embolic
material migrating into the venous systems with a
Figure 3. A 16-year-old girl had intracerebral hemorrhage relating to a tentorium arteriovenous fistula (AVF). (A) Right frontal carotid
angiogram showed a tentorium AVF with venous pouch. (B) Patient underwent transarterial Guglielmi detachable coil (GDC) embolization
resulting in total occlusion of the AVF; six GDCs with a total coil length of 94 cm were employed to occlude the AVF.
rapid increase in fistula pressure or pulmonary
embolization may have disastrous consequences when
the fistula is not occluded. Safe, effective therapy of
these fistulas often hinges on the deposition of embolic
material precisely at the fistula site, a task made more
difficult in rapid, high-flow AVFs.
Regarding the selection of embolic agents for
intracranial high-flow AVFs, a permanent embolic
material that can produce a mechanical obstruction of
shunting flow is effective. Common permanent embolic
agents employed for endovascular embolization of
intracranial high-flow AVFs include detachable balloon
and microcoils; on occasion, liquid adhesive has also
been used to occlude these high-flow fistulas.
TCCFs are usually treated with a detachable
balloon and have a promising outcome.13,14 However,
in patients with a tortuous ICA, small fistula tract,
small venous compartment, or intimal flap, the balloon
cannot be guided into such a position that the fistula
is occluded and the parent artery is preserved. In
addition, the sharp margins of bony fractures or foreign
bodies may rupture the balloon during inflation.8
In our series, we failed to negotiate the detachable
balloon into the cavernous sinus in 5 TCCFs. The
potential risks of over-manipulation of the detachable
balloon in these difficult patients may result in
thromboembolic events.
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Figure 4. A 39-year-old female had bilateral traumatic carotid-cavernous fistulas and received Guglielmi detachable coil embolization.
(A) Postembolization right frontal carotid angiogram revealed subtotal occlusion of the fistula with a small residual shunting flow. (B)
Follow-up angiogram 3 days later showed total obliteration of the residual shunting flow.
N-butyl-2-cyanoacrylate (NBCA) has been used
widely for embolization of intracranial arteriovenous
malformation and occasionally, low- and high-flow
intracranial AVFs.15–17 For high-flow AVFs, it has the
advantage of being relatively easy to deliver through
a microcatheter, producing rapid induction of
thrombosis and permanent occlusion after
polymerization. Theoretically, there are 2 main
potential disadvantages when NBCA is used as an
embolizing agent for treating high-flow AVFs. The
first is that highly concentrated NBCA polymerizes
very rapidly and tends to stick to the microcatheter.
The second drawback is the difficulty in controlling
the flow and polymerization of the NBCA and its cast
formation during embolization.
The use of a conventional microcoil alone has been
reported in the treatment of intracranial high-flow
AVFs.18 Technique pitfalls associated with embolization
performed with these coils include the impossibility of
easy retrieval, the relative stiffness of the coils, the risk
of perforation, and the difficulty of packing them
tightly. Moreover, complete obliteration of the fistula
may be difficult to achieve, and there is a risk of
impingement on the parent vessel and possible distal
coil migration. In our series, we found that GDC
could generally be deposited predictably at the desired
site, and that they could be observed prior to
detachment, to help ensure that the coil was in a secure
position, decreasing the chances of unintended passage
into the venous outlet. In addition, the coils are soft,
and can, therefore, be packed tightly into the targeted
vessels that they are intended to occlude. Also, when
compared with conventional microcoils, their
increased length allows a greater number of coils to
be delivered at one time, and their retrievability
allows suboptimally placed coils to be repositioned or
removed, so as to reduce the risk of coil migration to
the distal venous side. In addition, GDCs can act as
a template for the deposition of other embolic
materials such as NBCA, slowing flow and creating
turbulence to promote polymerization of the glue at
the fistula site. It can also provide a physical barrier to
the further movement of other embolic agents.8,15
However, GDCs are not without disadvantages.9,10
GDCs are not thrombogenic and they have less
space-filling capacity than balloons, which may result
in incomplete occlusion if the fistula cannot be densely
packed. Detachment of GDCs can take more than 1
hour in individual cases, especially when multiple
coils are used. Therefore, the GDC was thought by
some physicians as a suitable embolic material for
those AVFs with a small fistula tract.9,10 Furthermore,
GDCs are very expensive as compared with detachable
balloon and liquid adhesives. To reduce the cost, the
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combination of GDCs with other embolic materials,
such as liquid adhesives or other platinum coils, is
an alternative.
In our series, the GDC was used alone to occlude
the high-flow fistulas. Because the GDC itself is not
thrombogenic, many coils may be needed to achieve
mechanical blockage of a large shunting fistula. In the
present series, 2–13 coils with an average number of 8
and an average length of 126 cm were used to achieve
mechanical occlusion of the fistulous connection.
In the treatment of fistulas immediately adjacent to
a large parent artery, such as a TCCF, exact coil
positioning and the prevention of herniation into the
parent vessel are critical in minimizing the persistence
of pseudoaneurysms and embolic complications. In
our series, there was an asymptomatic pseudoaneurysm
formation at the cavernous ICA after total occlusion of
shunting flow. Subtotal obliteration of the fistulas
with small fistula flow was observed in 3 cases at the
end of the procedure. Spontaneous closure of the
residual fistulas was found on follow-up angiogram
3–4 days after embolization. Therefore, subtotal
occlusion with blockage of most parts of the fistula
tract that was associated with significant slowing down
of the shunting flow on angiography may not indicate
failure and does not appear to be a definite indication
to place more coils. However, follow-up angiogram is
mandatory to check the occurrence of spontaneous
thrombosis.
In this series, all patients were treated with GDCs
via the transarterial route with excellent results.
Transarterial GDC embolization is a useful method in
the treatment of intracranial high-flow AVFs. It affords
more control over the placement of coils and proves
both efficient and safe in the management of intracranial
high-flow AVFs.
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